Index 
 Previous 
 Next 
 Full text 
Procedure : 2016/2057(INI)
Document stages in plenary
Document selected : A8-0040/2017

Texts tabled :

A8-0040/2017

Debates :

PV 01/03/2017 - 24
CRE 01/03/2017 - 24

Votes :

PV 02/03/2017 - 6.6
Explanations of votes

Texts adopted :

P8_TA(2017)0061

Minutes
Wednesday, 1 March 2017 - Brussels

24. Options for improving access to medicines(debate)
CRE

Report on EU options for improving access to medicines [2016/2057(INI)] - Committee on the Environment, Public Health and Food Safety. Rapporteur: Soledad Cabezón Ruiz (A8-0040/2017)

Soledad Cabezón Ruiz introduced the report.

The following spoke: Vytenis Povilas Andriukaitis (Member of the Commission).

The following spoke: Piernicola Pedicini (rapporteur for the opinion of the DEVE Committee), Eleonora Evi (rapporteur for the opinion of the PETI Committee), Françoise Grossetête, on behalf of the PPE Group, Carlos Zorrinho, on behalf of the S&D Group, Bolesław G. Piecha, on behalf of the ECR Group, who also replied to a blue-card question by Janusz Korwin-Mikke, Gesine Meissner, on behalf of the ALDE Group, Kateřina Konečná, on behalf of the GUE/NGL Group, Mireille D'Ornano, on behalf of the ENF Group, Zoltán Balczó, non-attached Member, Pál Csáky, who also replied to a blue-card question by Kateřina Konečná, Damiano Zoffoli, Urszula Krupa, Luke Ming Flanagan, Andrey Kovatchev, Tiemo Wölken and Anna Záborská.

The following spoke: Vytenis Povilas Andriukaitis and Soledad Cabezón Ruiz.

The debate closed.

Vote: minutes of 2.3.2017, item 6.6.

Legal notice - Privacy policy